Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine
ABSTRACT Mycobacterium bovis BCG is the only available vaccine for protection against tuberculosis (TB). While BCG protects children from severe disease, it has little impact on pulmonary disease in adults. A recombinant BCG vaccine BCG ΔureC::hly (strain VPM1002) is in advanced clinical trials and...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
American Society for Microbiology
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d4d0396db66440578efc05f4568f5660 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:d4d0396db66440578efc05f4568f5660 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:d4d0396db66440578efc05f4568f56602021-11-15T15:50:19ZSleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine10.1128/mBio.01370-162150-7511https://doaj.org/article/d4d0396db66440578efc05f4568f56602016-09-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01370-16https://doaj.org/toc/2150-7511ABSTRACT Mycobacterium bovis BCG is the only available vaccine for protection against tuberculosis (TB). While BCG protects children from severe disease, it has little impact on pulmonary disease in adults. A recombinant BCG vaccine BCG ΔureC::hly (strain VPM1002) is in advanced clinical trials and shows promise for improved vaccine safety but little change in efficacy in animal models. A second-generation recombinant BCG vaccine with an additional deletion of the nuoG gene (BCG ΔureC::hly ΔnuoG) shows improved efficacy in a mouse model compared to that of VPM1002. BCG was first used in humans in 1921 and, like Sleeping Beauty pricked by the spinning wheel, we have slept for 100 years, showing a reluctance to invest in clinical development or in biomanufacturing capacity for TB vaccines. The advance of recombinant BCGs should awaken us from our sleep and call us to invest in new-generation TB vaccines and to protect the biomanufacture of our current BCG vaccine.Helen A. FletcherAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 4 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Microbiology QR1-502 |
| spellingShingle |
Microbiology QR1-502 Helen A. Fletcher Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine |
| description |
ABSTRACT Mycobacterium bovis BCG is the only available vaccine for protection against tuberculosis (TB). While BCG protects children from severe disease, it has little impact on pulmonary disease in adults. A recombinant BCG vaccine BCG ΔureC::hly (strain VPM1002) is in advanced clinical trials and shows promise for improved vaccine safety but little change in efficacy in animal models. A second-generation recombinant BCG vaccine with an additional deletion of the nuoG gene (BCG ΔureC::hly ΔnuoG) shows improved efficacy in a mouse model compared to that of VPM1002. BCG was first used in humans in 1921 and, like Sleeping Beauty pricked by the spinning wheel, we have slept for 100 years, showing a reluctance to invest in clinical development or in biomanufacturing capacity for TB vaccines. The advance of recombinant BCGs should awaken us from our sleep and call us to invest in new-generation TB vaccines and to protect the biomanufacture of our current BCG vaccine. |
| format |
article |
| author |
Helen A. Fletcher |
| author_facet |
Helen A. Fletcher |
| author_sort |
Helen A. Fletcher |
| title |
Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine |
| title_short |
Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine |
| title_full |
Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine |
| title_fullStr |
Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine |
| title_full_unstemmed |
Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine |
| title_sort |
sleeping beauty and the story of the bacille calmette-guérin vaccine |
| publisher |
American Society for Microbiology |
| publishDate |
2016 |
| url |
https://doaj.org/article/d4d0396db66440578efc05f4568f5660 |
| work_keys_str_mv |
AT helenafletcher sleepingbeautyandthestoryofthebacillecalmetteguerinvaccine |
| _version_ |
1718427428068524032 |